Prosonix Ltd, a UK specialty pharmaceutical group, has appointed Cécile Miles as chief business officer to help drive the development and commercialisation of its respiratory medicines. Ms Miles joins Prosonix from the Watson group (now known as Actavis Inc), where she was commercial director for the EU. Before that, she was executive director of commercial development at Ark Therapeutics Group Plc.
Prosonix announced the appointment on 11 February 2013.
Copyright 2013 Evernow Publishing Ltd.